Cargando…
Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world
As standard drug treatment of allergic rhinitis (AR) is not completely satisfactory, allergen immunotherapy (AIT) represents the only current treatment with the potential to modify the natural history. House dust mite (HDM) allergy is very common. The aim of the current experience was to describe th...
Autores principales: | Ciprandi, Giorgio, Natoli, Valentina, Puccinelli, Paola, Incorvaia, Cristoforo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320802/ https://www.ncbi.nlm.nih.gov/pubmed/28239397 http://dx.doi.org/10.1186/s13223-017-0185-x |
Ejemplares similares
-
The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis
por: Gelardi, Matteo, et al.
Publicado: (2018) -
Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021) -
The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
por: Incorvaia, Cristoforo, et al.
Publicado: (2011) -
Allergen specificity is relevant for immunotherapy prescription in polysensitised children
por: Ciprandi, Giorgio, et al.
Publicado: (2012) -
Characteristics of candidates for allergen immunotherapy
por: Ciprandi, Giorgio, et al.
Publicado: (2013)